Q3 2022 Holdings
Filed 2022-11-14 | 137 holdings | $217.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $87.6M | 650,000 | 40.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $53.0M | 150,000 | 24.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $48.5M | 1,000,000 | 22.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $7.5M | 1,000,000 | 3.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $4.8M | 500,000 | 2.2% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $3.2M | 250,000 | 1.5% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $2.8M | 1,646,517 | 1.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.5M | 250,000 | 1.1% |
| Adagene Inc(ADAG) | ADS | 005329107 | $1.3M | 1,000,000 | 0.6% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $1.2M | 750,000 | 0.5% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $1.1M | 105,347 | 0.5% |
| Avantor Inc(AVTR) | COM | 05352A100 | $882.0K | 45,000 | 0.4% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $409.0K | 500,000 | 0.2% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $396.6K | 5,000,000 | 0.2% |
| Adobe Systems Incorporated(ADBE) | COM | 00724F101 | $358.0K | 1,300 | 0.2% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $215.5K | 89,778,234 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $92.5K | 1,325,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $68.3K | 1,000,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $63.4K | 6,000,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $60.8K | 2,150,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $60.6K | 8,750,034 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $58.6K | 2,053,403 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $58.3K | 2,600,000 | 0.0% |
| WW Intl Inc(WW6) | COM | 98262P101 | $58.2K | 14,818,300 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $56.5K | 2,000,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $55.7K | 2,450,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $47.9K | 350,000 | 0.0% |
| Allovir Inc | COM | 019818103 | $44.0K | 5,577,167 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $41.8K | 4,000,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $38.9K | 3,246,624 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $36.8K | 4,750,000 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $34.9K | 500,000 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $32.7K | 1,500,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $32.5K | 1,454,716 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $29.4K | 750,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $28.1K | 125,000 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $24.7K | 3,172,221 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $20.8K | 2,285,574 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $19.8K | 4,000,000 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $18.4K | 600,000 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $17.5K | 700,000 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $15.5K | 900,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $15.4K | 275,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $15.0K | 1,100,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $14.9K | 2,814,191 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $14.9K | 2,200,000 | 0.0% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $14.8K | 1,720,720 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $13.7K | 400,000 | 0.0% |
| Seagen Inc(SGENUSD)Call | COM | 81181C104 | $13.7K | 100,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $13.5K | 750,000 | 0.0% |